Clinical Trial Detail

NCT ID NCT02981914
Title Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors University of Chicago
Indications

myelodysplastic syndrome

acute myeloid leukemia

mature B-cell neoplasm

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.